Search

OPKO Health Inc

Cerrado

SectorSanidad

1.62 -1.22

Resumen

Variación precio

24h

Actual

Mínimo

1.6400000000000001

Máximo

1.65

Métricas clave

By Trading Economics

Ingresos

46M

-8.4M

Ventas

39M

164M

BPA

-0.01

Margen de beneficios

-5.145

Empleados

2,275

EBITDA

40M

12M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+82.93% upside

Dividendos

By Acuity

Próximas Ganancias

28 oct 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

355M

1.3B

Apertura anterior

2.84

Cierre anterior

1.62

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

102 / 339 Clasificación en Healthcare

OPKO Health Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

25 sept 2026, 20:07 UTC

OPKO Health Inc is trading higher amid a broader market rally, which closed above its 20-day moving average despite ongoing economic concerns.

24 sept 2026, 23:01 UTC

OPKO Health Inc is trading modestly higher in after-market hours, rebounding from three consecutive lower daily closes amid mixed performance in the health care services sector.

23 sept 2026, 21:50 UTC

OPKO Health Inc declined in after-market trading, shifting from a positive return to a negative one since Wednesday's close, settling at the day's lowest point.

22 sept 2026, 23:01 UTC

OPKO Health Inc is trading lower in after-market hours, declining notably from its peak, amid concerns following the unexpected drop in the Richmond Fed Manufacturing Index.

21 sept 2026, 23:10 UTC

OPKO Health Inc's shares declined modestly in after-market trading on Monday, falling to their lowest point of the day despite remaining above the 20-day moving average.

17 sept 2026, 20:07 UTC

OPKO Health Inc's stock is roughly flat, remaining above its 20-day moving average and near the upper end of its one-month trading range.

16 sept 2026, 19:03 UTC

OPKO Health Inc is seeing upward movement, currently trading significantly above its 20-day moving average and near the upper end of its one-month range.

15 sept 2026, 23:11 UTC

OPKO Health Inc shares are higher in after-market trading, advancing from a low of 1.28% to a high of 1.92% since Tuesday's close.

14 sept 2026, 20:08 UTC

News

OPKO Health has expanded its financing with HealthCare Royalty, securing $125 million in senior secured notes linked to future royalty payments in China.

11 sept 2026, 20:01 UTC

OPKO Health Inc shares are higher, continuing gains since Thursday's close. The stock rebounded after an early dip, with no specific news driving the movement.

9 sept 2026, 19:16 UTC

OPKO Health Inc. shares are lower today amid broader market pressures from rising oil prices above $100 per barrel and inflation concerns.

8 sept 2026, 23:36 UTC

No specific news was identified for OPKO Health Inc. Shares traded roughly flat after market hours, remaining near the upper end of their one-month range.

4 sept 2026, 20:07 UTC

OPKO Health Inc. shares are higher today, rebounding significantly after an initial dip and currently 12.75% above the 20-day moving average.

3 sept 2026, 21:02 UTC

OPKO Health Inc. is higher in after-hours trading, reflecting gains since Thursday's close amid declining Treasury yields and improved investor sentiment.

2 sept 2026, 23:46 UTC

OPKO Health Inc. shares were roughly flat during after-market hours, maintaining a significant one-month increase of about 29%.

1 sept 2026, 20:01 UTC

OPKO Health shares are higher today, remaining above their 20-day moving average amid rising oil prices and inflation concerns affecting the broader market.

28 ago 2026, 19:16 UTC

OPKO Health Inc. shares are lower today, having reached a session low. The stock remains within its one-month trading range and above the 20-day moving average.

27 ago 2026, 23:01 UTC

OPKO Health Inc. shares are higher in after-market trading, reflecting strong performance since Thursday's close and maintaining a position above its 20-day moving average.

26 ago 2026, 20:08 UTC

OPKO Health Inc shares are higher during Wednesday's session, maintaining a position above the 20-day moving average amid mixed broader market performance.

25 ago 2026, 19:36 UTC

OPKO Health Inc. shares are higher today, remaining above their 20-day moving average despite earlier fluctuations during the session.

24 ago 2026, 22:01 UTC

OPKO Health Inc. shares are lower in after-market trading, reflecting a shift in momentum since Monday's close. The stock remains above its 20-day moving average.

21 ago 2026, 23:56 UTC

OPKO Health Inc. shares declined in after-market trading, despite gains in major stocks as the broader market rebounded from earlier pressures.

20 ago 2026, 19:56 UTC

OPKO Health Inc. shares are higher today, maintaining a position above their 20-day moving average amid no specific company news identified.

19 ago 2026, 20:02 UTC

OPKO Health Inc shares are higher in Wednesday's session, recovering from an early dip. The stock remains above its 20-day moving average.

18 ago 2026, 19:16 UTC

OPKO Health Inc shares are lower amid broader market declines, influenced by rising Treasury yields and inflation concerns following a significant drop in housing starts.

17 ago 2026, 19:06 UTC

News

OPKO Health Inc. shares are lower today, continuing a decline since Friday. The company issued $125 million in senior secured notes linked to mazdutide royalties.

14 ago 2026, 19:36 UTC

OPKO Health Inc shares are lower amid broader market concerns following a reported decline in retail sales for July. The stock reached a session low earlier.

13 ago 2026, 23:01 UTC

OPKO Health shares lower in after-market trading, declining since Thursday's close amid mixed macroeconomic signals and uncertainty in the market.

12 ago 2026, 19:36 UTC

OPKO Health Inc shares are modestly higher, reflecting a positive market environment amid recent risk asset gains. Core CPI data aligns with forecasts, supporting steady interest rates.

11 ago 2026, 19:36 UTC

OPKO Health Inc shares are higher, maintaining a position above their 20-day moving average amid broader market sentiment influenced by geopolitical tensions and inflation reports.

Comparación entre iguales

Cambio de precio

OPKO Health Inc previsión

Precio Objetivo

By TipRanks

82.93% repunte

Estimación a 12 Meses

Media 3 USD  82.93%

Máximo 3 USD

Mínimo 3 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para OPKO Health Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

3 ratings

2

Comprar

1

Mantener

0

Vender

Sentimiento

By Acuity

102 / 339 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de OPKO Health Inc

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 2007 and is headquartered in Miami, Florida.